105 related articles for article (PubMed ID: 28291803)
1. Induction of Hsp70 in tumor cells treated with inhibitors of the Hsp90 activity: A predictive marker and promising target for radiosensitization.
Kudryavtsev VA; Khokhlova AV; Mosina VA; Selivanova EI; Kabakov AE
PLoS One; 2017; 12(3):e0173640. PubMed ID: 28291803
[TBL] [Abstract][Full Text] [Related]
2. HSP90 inhibition acts synergistically with heat to induce a pro-immunogenic form of cell death in colon cancer cells.
Mouratidis PXE; Ter Haar G
Int J Hyperthermia; 2021; 38(1):1443-1456. PubMed ID: 34612127
[TBL] [Abstract][Full Text] [Related]
3. Capsaicin binds the N-terminus of Hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin).
Patwardhan CA; Kommalapati VK; Llbiyi T; Singh D; Alfa E; Horuzsko A; Korkaya H; Panda S; Reilly CA; Popik V; Chadli A
Sci Rep; 2023 Aug; 13(1):13790. PubMed ID: 37612326
[TBL] [Abstract][Full Text] [Related]
4. National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.
George TJ; Franke AJ; Chakravarthy AB; Das P; Dasari A; El-Rayes BF; Hong TS; Kinsella TJ; Landry JC; Lee JJ; Monjazeb AM; Jacobs SA; Raben D; Rahma OE; Williams TM; Wu C; Coleman CN; Vikram B; Ahmed MM
Cancer; 2019 Aug; 125(16):2732-2746. PubMed ID: 31017664
[TBL] [Abstract][Full Text] [Related]
5. Chemical modulators of heat shock protein 70 (Hsp70) by sequential, microwave-accelerated reactions on solid phase.
Wisén S; Androsavich J; Evans CG; Chang L; Gestwicki JE
Bioorg Med Chem Lett; 2008 Jan; 18(1):60-5. PubMed ID: 18060774
[TBL] [Abstract][Full Text] [Related]
6. Heat Shock Protein 70 and 90 Family in Prostate Cancer.
Fu X; Liu J; Yan X; DiSanto ME; Zhang X
Life (Basel); 2022 Sep; 12(10):. PubMed ID: 36294924
[TBL] [Abstract][Full Text] [Related]
7. Development of Noviomimetics as C-Terminal Hsp90 Inhibitors.
Anyika M; McMullen M; Forsberg LK; Dobrowsky RT; Blagg BS
ACS Med Chem Lett; 2016 Jan; 7(1):67-71. PubMed ID: 26819668
[TBL] [Abstract][Full Text] [Related]
8. HSP70 Is a Critical Regulator of HSP90 Inhibitor's Effectiveness in Preventing HCl-Induced Chronic Lung Injury and Pulmonary Fibrosis.
Colunga Biancatelli RML; Solopov PA; Day T; Gregory B; Osei-Nkansah M; Dimitropoulou C; Catravas JD
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339194
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of cancer cell death induction by triptolide: A comprehensive overview.
Feng K; Li X; Bai Y; Zhang D; Tian L
Heliyon; 2024 Jan; 10(2):e24335. PubMed ID: 38293343
[TBL] [Abstract][Full Text] [Related]
10. ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors.
Mainwaring OJ; Weishaupt H; Zhao M; Rosén G; Borgenvik A; Breinschmid L; Verbaan AD; Richardson S; Thompson D; Clifford SC; Hill RM; Annusver K; Sundström A; Holmberg KO; Kasper M; Hutter S; Swartling FJ
Nat Commun; 2023 Mar; 14(1):1221. PubMed ID: 36869047
[TBL] [Abstract][Full Text] [Related]
11. Decreased Levels of Chaperones in Mucopolysaccharidoses and Their Elevation as a Putative Auxiliary Therapeutic Approach.
Żabińska M; Gaffke L; Bielańska P; Podlacha M; Rintz E; Cyske Z; Węgrzyn G; Pierzynowska K
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840025
[TBL] [Abstract][Full Text] [Related]
12. Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models.
Xu P; Yang JC; Ning S; Chen B; Nip C; Wei Q; Liu L; Johnson OT; Gao AC; Gestwicki JE; Evans CP; Liu C
Pharmacol Res; 2023 Mar; 189():106692. PubMed ID: 36773708
[TBL] [Abstract][Full Text] [Related]
13. Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials.
Nishikawa S; Iwakuma T
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672377
[TBL] [Abstract][Full Text] [Related]
14. Advances in the study of HSP70 inhibitors to enhance the sensitivity of tumor cells to radiotherapy.
Du S; Liu Y; Yuan Y; Wang Y; Chen Y; Wang S; Chi Y
Front Cell Dev Biol; 2022; 10():942828. PubMed ID: 36036010
[TBL] [Abstract][Full Text] [Related]
15. Cordycepin (3'-Deoxyadenosine) Suppresses Heat Shock Protein 90 Function and Targets Tumor Growth in an Adenosine Deaminase-Dependent Manner.
Lee SC; Alaali L; Kwon H; Rigi M; Eberhart CG
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804893
[TBL] [Abstract][Full Text] [Related]
16. Rational design of synthetically tractable HDAC6/HSP90 dual inhibitors to destroy immune-suppressive tumor microenvironment.
Wu TY; Chen M; Chen IC; Chen YJ; Chen CY; Wang CH; Cheng JJ; Nepali K; Chuang KH; Liou JP
J Adv Res; 2023 Apr; 46():159-171. PubMed ID: 35752438
[TBL] [Abstract][Full Text] [Related]
17. The Heat Shock Protein 90 Inhibitor, AT13387, Protects the Alveolo-Capillary Barrier and Prevents HCl-Induced Chronic Lung Injury and Pulmonary Fibrosis.
Colunga Biancatelli RML; Solopov P; Dimitropoulou C; Gregory B; Day T; Catravas JD
Cells; 2022 Mar; 11(6):. PubMed ID: 35326496
[TBL] [Abstract][Full Text] [Related]
18. Transferrin Modified GSH Sensitive Hyaluronic Acid Derivative Micelle to Deliver HSP90 Inhibitors to Enhance the Therapeutic Efficacy of Brain Cancers.
Debele TA; Wu PC; Wei YF; Chuang JY; Chang KY; Tsai JH; Su WP
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069106
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Proteomics Reveals that Hsp90 Inhibition Dynamically Regulates Global Protein Synthesis in Leishmania mexicana.
Kalesh K; Sundriyal S; Perera H; Cobb SL; Denny PW
mSystems; 2021 May; 6(3):. PubMed ID: 33975965
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing.
Kabakov AE; Yakimova AO
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33806538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
